Teva Pharmaceutical Industries Ltd. | Key People and Executives
Kåre Schultz
President, Chief Executive Officer & Director
Ronit Satchi-Fainaro
Director
Amir Elstein
Independent Director
Nechemia J. Peres
Independent Director
Perry Nisen
Independent Director
Roberto Agostino Mignone
Independent Director
Murray A. Goldberg
Independent Director
Gerald M. Lieberman
Independent Director
Rosemary A. Crane
Independent Director
Jean-Michael Halfon
Independent Director
Kåre Schultz
President, Chief Executive Officer & Director
Carlo de Notaristefani
Executive Vice President-Global Operations
Michael McClellan
Chief Financial Officer & Executive Vice President
Sven Dethlefs
Executive VP- Global Marketing & Portfolio
Brendan O'Grady
Executive Vice President-North America Commercial
Hafrun Fridriksdottir
Executive VP-Global Research & Development
Richard Daniell
Executive Vice President-European Commercial
Tushar Shah
Head-Late Stage Development
Marcelo Bigal
Chief Medical Officer & Head-Specialty Clinical
Brian E. Shanahan
VP & Deputy General Counsel-Transactions
Ronit Satchi-Fainaro
Director
Iris Beck Codner
Vice President-Global Brand & Communications
Nir Baron
Chief Internal Auditor & Executive Vice President
Deborah A. Griffin
Chief Accounting Officer & Senior Vice President
Kevin C. Mannix
Senior Vice President
Mark Sabag
Executive Vice President-Global Human Resources
David Stark
Chief Legal Officer & Executive Vice President
Amir Elstein
Independent Director
Nechemia J. Peres
Independent Director
Perry D. Nisen
Independent Director
Roberto Agostino Mignone
Independent Director
Murray A. Goldberg
Independent Director
Gerald M. Lieberman
Independent Director
Rosemary A. Crane
Independent Director
Jean-Michael Halfon
Independent Director
| Address |
5 Basel Street
Petach Tikva HM 49131
Israel
|
|
Employees
|
- |
| Website |
http://www.tevapharm.com |
| Updated |
07/08/2019 |
| Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which engages in development, production and marketing of drugs, generic drugs, over-the-counter drugs, active ingredients for the pharmaceutical industry (APIs) and therapeutic products. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. |
